3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
The present invention provides a compound of the following Formula (1) or a pharmaceutically acceptable salt thereof: wherein X is an oxygen atom and the like; Y is —CO—, —SO 2 — and the like; R 1 is an optionally-substituted C 1-6 alkyl group, an optionally-substituted C 1-6 alkylcarbonyl group and the like; R 2 is an optionally-substituted C 1-6 alkyl group, an optionally-substituted C 1-6 alkoxy group, an optionally-substituted amino group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic saturated heterocyclic group and the like; R 3 , R 4 , R 5 , and R 6 are independently a hydrogen atom and the like which exhibits excellent effects in suppressing the proliferation and sphere-forming ability of cancer cells, and can be useful as an antitumor drug or cell growth inhibitor.
1. A compound of Formula (1):
or a pharmaceutically acceptable salt thereof
wherein
X is NR 7 ; Y is —CO—, —CS—, —SO—, or —SO 2 —;
R 1 is a hydrogen atom, a halogen atom, a cyano group, a nitro group, an optionally-substituted C 1-6 alkoxy group, a substituted amino group, an optionally-substituted C 1-6 alkylcarbonyl group, an optionally-substituted C 3-10 cycloalkyl group, an optionally-substituted C 3-10 cycloalkylcarbonyl group, an optionally-substituted 3- to 8-membered saturated heterocyclic group, an optionally-substituted 3- to 8-membered saturated heterocyclic carbonyl group, an optionally-substituted C 6-10 arylcarbonyl group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroaryl group, or an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroarylcarbonyl group;
R 2 is a hydrogen atom, a hydroxy group, an optionally-substituted C 1-6 alkyl group, an optionally-substituted C 1-6 alkoxy group, an optionally-substituted amino group, an optionally-substituted C 3-10 cycloalkyl group, an optionally-substituted 3- to 8-membered saturated heterocyclic group, or an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroaryl group;
R 3 , R 4 , R 5 , and R 6 are independently a hydrogen atom, a halogen atom, a cyano group, a nitro group, a hydroxy group, an optionally-substituted C 1-6 alkyl group, an optionally-substituted C 2-6 alkenyl group, an optionally-substituted C 2-6 alkynyl group, an optionally-substituted C 1-6 alkoxy group, an optionally-substituted C 1-6 alkylthio group, an optionally-substituted C 6-10 arylthio group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroarylthio group, an optionally-substituted C 1-6 alkylsulfinyl group, an optionally-substituted C 6-10 arylsulfinyl group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroarylsulfinyl group, an optionally-substituted C 1-6 alkylsulfonyl group, an optionally-substituted C 6-10 arylsulfonyl group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroarylsulfonyl group, an optionally-substituted amino group, an optionally-substituted C 1-6 alkylcarbonyl group, an optionally-substituted C 3-10 cycloalkyl group, an optionally-substituted C 3-10 cycloalkenyl group, an optionally-substituted 3- to 8-membered saturated heterocyclic group, an optionally-substituted C 6-10 aryl group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroaryl group, a C 1-6 alkylsulfinyl group, an optionally-substituted C 3-10 cycloalkylsulfinyl group, an optionally-substituted C 1-6 alkylsulfonyl group, or an optionally-substituted C 3-10 cycloalkylsulfonyl group; and
R 7 is an optionally-substituted C 1-6 alkylcarbonyl group, an optionally-substituted C 3-10 cycloalkyl group, an optionally-substituted 3- to 8-membered saturated heterocyclic group, or an optionally-substituted 5- to 12-membered monocyclic or polycyclic heteroaryl group.